Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Investing in a better flu shot
Markewatch
Tuesday, November 27, 2012 - 10:29am
tags:
vaccines, Flu, GSK, AstraZeneca, Sanofi
Merck KGaA to resist lure of potential proceeds from OTC sale
Reuters
Tuesday, November 27, 2012 - 10:27am
tags:
OTC, M&A, Merck KGaA, Schiff
Abbot’s Spin-Off Abbvie: A Step in the Right Direction
Motley Fool
Tuesday, November 27, 2012 - 10:25am
tags:
AbbVie, Abbott Labs
J&J preps case for quick FDA approval of new TB drug
Fierce Biotech
Monday, November 26, 2012 - 12:21pm
tags:
JNJ, FDA, tuberculosis, bedaquiline
Eisai Insurer Balks At Paying Whistleblower Claim
Pharmalot
Monday, November 26, 2012 - 12:07pm
tags:
Eisai, whistleblower lawsuits
GlaxoSmithKline Positioning For Clinical Trial Data Advantage
Seeking Alpha
Monday, November 26, 2012 - 12:06pm
tags:
GSK, clinical trials
3 Difficult-To-Understand Trends In Biotechnology
Seeking Alpha
Monday, November 26, 2012 - 11:13am
tags:
Questcor, Spectrum Pharmaceuticals, NeoStem
mRNA vaccines protect against viral infections in study
Pharmaceutical Business Review
Monday, November 26, 2012 - 11:11am
tags:
vaccines, MRNA, CureVac
Why Somaxon Pharmaceuticals Should Be A Double From Here
Seeking Alpha
Monday, November 26, 2012 - 11:06am
tags:
Somaxon
Roche to Cochrane critics: Let's compromise on Tamiflu data
Fierce Pharma
Monday, November 26, 2012 - 11:03am
tags:
Roche, Tamiflu
Cubist Pharmaceuticals: Promising Biotech For The Future
Seeking Alpha
Monday, November 26, 2012 - 11:01am
tags:
Cubist Pharmaceuticals, Teva, Entereg, Cubicin
Novartis To UK: Speed Drug Approvals, Or Else
Pharmalot
Monday, November 26, 2012 - 10:58am
tags:
UK, drug approvals, Novartis
Anika Therapeutics: Growth Stock At Value Prices With Near-Term FDA Catalyst
Seeking Alpha
Monday, November 26, 2012 - 10:57am
tags:
FDA, Anika
2 Important Decisions to Watch For This Week in the Biotech Sector
Motley Fool
Monday, November 26, 2012 - 10:56am
tags:
Theravance, Vibativ, cabozantinib, Exelis, medullary thyroid cancer, pneumonia
Exelixis's Cabozantinib Should Receive FDA Approval, But Faces Long-Term Challenges
Seeking Alpha
Monday, November 26, 2012 - 10:55am
tags:
cabozantinib, FDA, Exelixis, medullary thyroid cancer
Sucampo and Abbott Announce Launch of AMITIZA in Japan
Yahoo
Monday, November 26, 2012 - 10:54am
tags:
Abbott Labs, Sucampo, constipation, Japan, Amitiza
After 2 Drug Approvals, Can Supernus Deliver In 2013?
Seeking Alpha
Monday, November 26, 2012 - 10:26am
tags:
Supernus Pharmaceuticals, SPN-810, epilepsy, Oxtellar XR, ADHD
GSK initiates open offer to increase stake in Consumer Healthcare unit in India
Yahoo/Fly on the Wall
Monday, November 26, 2012 - 10:24am
tags:
India, GSK
The Easy Way to Make Millions on Biotechs
Motley Fool
Sunday, November 25, 2012 - 11:25am
tags:
insider trading, legal
China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial Results
Yahoo/GlobeNewsWire
Sunday, November 25, 2012 - 11:17am
tags:
China Nuokang Bio-Pharmaceutical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.